These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 16566587

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Superoxide reactivity of KatG: insights into isoniazid resistance pathways in TB.
    Ghiladi RA, Cabelli DE, Ortiz de Montellano PR.
    J Am Chem Soc; 2004 Apr 21; 126(15):4772-3. PubMed ID: 15080669
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Conformational differences in Mycobacterium tuberculosis catalase-peroxidase KatG and its S315T mutant revealed by resonance Raman spectroscopy.
    Kapetanaki S, Chouchane S, Girotto S, Yu S, Magliozzo RS, Schelvis JP.
    Biochemistry; 2003 Apr 08; 42(13):3835-45. PubMed ID: 12667074
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mycobacterium tuberculosis KatG(S315T) catalase-peroxidase retains all active site properties for proper catalytic function.
    Kapetanaki SM, Chouchane S, Yu S, Zhao X, Magliozzo RS, Schelvis JP.
    Biochemistry; 2005 Jan 11; 44(1):243-52. PubMed ID: 15628865
    [Abstract] [Full Text] [Related]

  • 8. Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities.
    Cade CE, Dlouhy AC, Medzihradszky KF, Salas-Castillo SP, Ghiladi RA.
    Protein Sci; 2010 Mar 11; 19(3):458-74. PubMed ID: 20054829
    [Abstract] [Full Text] [Related]

  • 9. Crystallographic and pre-steady-state kinetics studies on binding of NADH to wild-type and isoniazid-resistant enoyl-ACP(CoA) reductase enzymes from Mycobacterium tuberculosis.
    Oliveira JS, Pereira JH, Canduri F, Rodrigues NC, de Souza ON, de Azevedo WF, Basso LA, Santos DS.
    J Mol Biol; 2006 Jun 09; 359(3):646-66. PubMed ID: 16647717
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The mechanism of action of isoniazid. A chemical model of activation].
    Bernadou J, Nguyen M, Meunier B.
    Ann Pharm Fr; 2001 Sep 09; 59(5):331-7. PubMed ID: 11787427
    [Abstract] [Full Text] [Related]

  • 19. Computational approach to understanding the mechanism of action of isoniazid, an anti-TB drug.
    Jena L, Waghmare P, Kashikar S, Kumar S, Harinath BC.
    Int J Mycobacteriol; 2014 Dec 09; 3(4):276-82. PubMed ID: 26786627
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.